CTOs on the Move

NARBHA

www.narbha.org

 
Northern Arizona Regional Behavioral Health Authority (NARBHA) was founded in 1967.  It is a private, not-for-profit managed care corporation designated by the Arizona Department of Health Services as being responsible for the planning, implementation, funding, monitoring and administration of publicly funded comprehensive behavioral health services in Northern Arizona. NARBHA serves over 700,000 people throughout 62,000 square miles (or ½ of the state) of northern Arizona, including the Hopi Reservation. NARBHA subcontracts with ten Responsible Agencies (RAs), over 70 additional behavioral health providers, and operated under Memorandums of Understanding (MOU) with ten Native American tribes, offering choice of services to members throughout ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.narbha.org
  • 1300 S Yale St
    Flagstaff, AZ USA 86001-6328
  • Phone: 928.774.7128

Executives

Name Title Contact Details

Similar Companies

Paid Claims

Paid Claims is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Adia Information Management

Adia Information Management Corp. is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genome Quebec Pharmacogenomics Centre

Southern KY AHEC

Southern KY AHEC is a Mount Vernon, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

scPharmaceuticals

scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.